Evaluation of ciprofloxacin as a representative of veterinary fluoroquinolones in susceptibility testing

Journal of Clinical Microbiology

Volumn 38, Issue 4, 2000, Pages 1636-1637

  Riddle, Christa ^a   Lemons, Carol L ^a   Papich, Mark G ^a   Altier, Craig ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; ENROFLOXACIN; MARBOFLOXACIN; ORBIFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; UNCLASSIFIED DRUG;

ANTIBIOTIC SENSITIVITY; ARTICLE; DOG; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; QUALITY CONTROL; STAPHYLOCOCCUS AUREUS; TURTLE; VETERINARY MEDICINE;

ANIMALIA; CANIS FAMILIARIS; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; TESTUDINES;

EID: 0034003934     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.38.4.1636-1637.2000     Document Type: Article

References (8)

1. Crumplin, G. C., and J. T. Smith. 1976. Nalidixic acid and bacterial chromosome replication. Nature 260:643-645.
2. Gellert, M., K. Mizuuchi, M. H. O'Dea, T. Itoh, and J.-I. Tomazawa. 1977. Nalidixic acid resistance: a second genetic character involved in DNA gyrase activity. Proc. Natl. Acad. Sci. USA 74:4772-4776.
3. Ihrke, P. J., M. G. Papich, and T. C. Demanuelle. 1999. The use of fluoroquinolones in veterinary dermatology. Vet. Dermatol. 10:193-204.
4. Lauderdale, T.-L., K. C. Chapin, and P. R. Murray. 1999. Reagents, p. 1665-1673. In P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 7th ed. American Society for Microbiology, Washington, D.C.
5. Marshall, S. A., R. N. Jones, A. Wanger, J. A. Washington, G. V. Doern, A. L. Leber, and T. H. Haugen. 1996. Proposed MIC quality control guidelines for National Committee for Clinical Laboratory Standards susceptibility tests using seven veterinary antimicrobial agents: ceftiofur, enrofloxacin, florfenicol, penicillin G-novobiocin, pirlimycin, premafloxacin, and spectinomycin. J. Clin. Microbiol. 34:2027-2029.
6. National Committee for Clinical Laboratory Standards. 1997. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 4th ed. Approved standard M7-A4. National Committee for Clinical Laboratory Standards, Wayne, Pa.
7. National Committee for Clinical Laboratory Standards. 1999. Performance standards for antimicrobial susceptibility testing. Eighth informational supplement M1000-S9. National Committee for Clinical Laboratory Standards, Wayne, Pa.
8. National Committee for Clinical Laboratory Standards. 1999. Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals. Approved standard M31-A. National Committee for Clinical Laboratory Standards. Wayne, Pa.